Low-dose tenecteplase versus standard-dose alteplase for acute ischaemic stroke: an Imaging-Based Efficacy Trial.
Phase of Trial: Phase II
Latest Information Update: 13 Dec 2016
At a glance
- Drugs Tenecteplase (Primary) ; Alteplase
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms TAAIS
- 13 Dec 2016 Results of pooled post-hoc analysis from TAAIS and ATTEST studies (n=146) published in the Circulation.
- 22 Mar 2012 Results published in the New England Journal of Medicine.
- 08 Feb 2012 Status changed from recruiting to completed.